We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

AFL:NYSEAFLAC Incorporated Analysis

Data as of 2026-05-25 - not real-time

$117.86

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Aflac’s stock is trading at $117.86, comfortably above its 20‑day ($115.60), 50‑day ($112.62) and 200‑day ($110.60) simple moving averages, confirming a bullish technical backdrop. The MACD line sits at 1.35 above its signal at 1.18, delivering a bullish histogram, while the RSI of 61.8 signals strength without being overbought. With a beta near 0.13 and 30‑day volatility of roughly 14.4%, the equity exhibits low market‑risk sensitivity, and the price is supported at $109.55 with resistance near $119.81. On the fundamentals side, the company posts a 27.9% revenue growth rate, a solid 29.6% operating margin, and a 16.5% ROE, all while trading at a forward‑PE of 15.5 versus an industry average of 16.8, indicating relative cheapness. The dividend yield of 2.07% is backed by a modest 27% payout ratio and robust free cash flow, supporting sustainability. Overall, the blend of bullish technical signals and attractive valuation metrics positions AFL as a potential upside play.
However, recent analyst activity has been mixed, with Piper Sandler lowering its price target after a quarterly miss and insiders selling $4.9 M of stock, injecting some caution. Despite this, the dividend narrative remains strong, and the company’s diversified exposure across the U.S. and Japan provides a balanced geographic profile. Investors should weigh the short‑term price proximity to resistance against the longer‑term fundamentals and dividend appeal.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term resistance at $119.81
  • Bullish MACD and RSI indicating momentum
  • Recent analyst downgrades and insider sales

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to peers (PE 13.5 vs 16.8 industry)
  • Strong revenue growth and operating margins
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistent cash flow generation supporting dividend growth
  • Diversified geographic exposure (U.S. and Japan)
  • Low beta and modest volatility reducing market risk

Key Metrics & Analysis

Financial Health

Revenue Growth27.90%
Profit Margin25.60%
P/E Ratio13.5
ROE16.47%
ROA3.09%
Debt/Equity48.28
P/B Ratio2.0
Op. Cash Flow$2.9B
Free Cash Flow$4.9B
Industry P/E16.8

Technical Analysis

TrendBullish
RSI61.8
Support$109.55
Resistance$119.81
MA 20$115.60
MA 50$112.62
MA 200$110.60
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$331.87
Target Price$112.07
Upside/Downside-4.91%
GradeUndervalued
TypeBlend
Dividend Yield2.07%

Risk Assessment

Beta0.13
Volatility14.44%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.